Introduction
============

Depression is a prevalent chronic mental disorder with high rates of recurrence, disability, and suicide, and it is often characterized by significant and persistent depressive disorder.[@b1-ndt-15-021] Nowadays, along with the acceleration and change in lifestyle, the stress increases due to many aspects such as employment, social competition, and interpersonal communication, which leads to a gradual increase in the incidence of depression. According to WHO, depression has become one of the major causes of disability in the world, and it may become one of the main causes of the increased burden of disease and medical cost by 2030.[@b2-ndt-15-021],[@b3-ndt-15-021] Monoamine neurotransmitter hypothesis is one of the core concepts of depressive disorder caused by stress. The hypothesis suggests that the reduction or absence of 5-hydroxytryptamine (5-HT), norepinephrine (NE) or other monoamine neurotransmitters in the central and peripheral regions may cause the depression.[@b4-ndt-15-021],[@b5-ndt-15-021]

5-HT, the most important intermediate metabolite in the tryptophan metabolism, is composed of indole and ethylamine. The decrease in 5-HT level in the central nervous system will enhance the sensitivity of the body to stress and make it more vulnerable to external injury, which leads to the depression or other mental disorders.[@b6-ndt-15-021] A study has shown that the dysfunction of the 5-HT system is closely related to depression, anorexia, insomnia, circadian rhythm disorder, endocrine dysfunction, sexual dysfunction, anxiety disorder and reduced activity.[@b7-ndt-15-021] Tryptophan hydrogenase (TPH) is the only rate-limiting enzyme of the 5-HT synthesis pathway, which is an important prerequisite for 5-HT synthesis and may be used as a specific marker of 5-HT neurons.[@b8-ndt-15-021] Tryptophan hydrogenase 2 (TPH2) is a subtype of TPH that mainly controls the synthesis of central 5-HT, the abnormal expression of which may result in affective disorder and suicidal behavior.[@b9-ndt-15-021] Indoleamine 2,3-dioxygenase 1 (IDO1) is a tryptophan-degrading enzyme whose increased activity may lead to increase in the formation of kynurenine due to tryptophan metabolism, resulting in the decrease in 5-HT synthesis.[@b10-ndt-15-021] Therefore, the abnormal expression of TPH2 and IDO1 may cause the dysfunction of the 5-HT system, leading to the occurrence of mental disorders such as depression. Hippocampus is rich in various neurotransmitters and receptors and is closely related to emotion. It is the high-regulation center of the stress response, and its structure and function could be changed by chronic stress.[@b11-ndt-15-021] Hippocampus is also a target of stress hormones, and stress and high glucocorticoids can affect the hippocampal neuroplasticity.[@b12-ndt-15-021] It is reported that *TPH2* gene is expressed in the hippocampus and raphe nuclei,[@b13-ndt-15-021] and IDO1 has a certain effect on the function and structure of hippocampal neurons.[@b14-ndt-15-021] Therefore, hippocampus may be a key region to observe the stress-induced changes in TPH2 and IDO1 in the 5-HT system.

Xiaoyaosan, a classic Chinese formula in the book *Prescriptions of the Bureau of Taiping People's Welfare Pharmacy*, originates from the Song Dynasty of China. It has the effects of dispersing stagnated liver qi for relieving qi stagnation, nourishing blood and strengthening spleen.[@b15-ndt-15-021] Xiaoyaosan has obvious comprehensive efficacy in treating depression caused by stress and other complex psychiatric disorders.[@b16-ndt-15-021] Hippocampus is the most important area of the brain responsible for learning, memory and emotion regulation, and the malfunction of hippocampus could directly lead to the decline in the ability of learning, memory and emotional control.[@b17-ndt-15-021] It is found that Xiaoyaosan has a certain regulatory effect on the structure and function of hippocampus, and hippocampus may play a key role in the antidepressant efficacy of Xiaoyaosan.[@b18-ndt-15-021],[@b19-ndt-15-021] One recent study indicates that the therapeutic effects of Xiaoyaosan may be associated with the function of the 5-HT system,[@b20-ndt-15-021] but how Xiaoyaosan affects the synthesis of 5-HT through the tryptophan metabolism is still not understood.

Therefore, we used chronic immobilization stress (CIS) to establish the depression model of rats, and then we used ELISA to detect the levels of 5-HT and tryptophan and Western blot and quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) to measure the expression of TPH2 and IDO1, in order to assess the influence of Xiaoyaosan on the tryptophan metabolism, which is responsible for the increase in the synthesis and function of 5-HT in the hippocampi of chronic stress-depressed rats.

Materials and methods
=====================

Animals
-------

The specific pathogen-free (SPF) healthy male Sprague Dawley (SD) rats (12-week old; SCXK (Beijing) 2012-0001) were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd. (Beijing, China) and then fed in a standard animal feeding room (temperature: 20°C--24°C; relative humidity: 30%--40% and light condition: 12-hour/12-hour dark/light cycle for all the experiments).

All animal experiments in the study were approved by the Institutional Animal Care and Use Committee at Beijing University of Chinese Medicine and complied with the Animal Management Rules of the Chinese Ministry of Health and existing current animal welfare guidelines.

Preparation of Xiaoyaosan
-------------------------

The compound used in the experiment is Xiaoyaosan, which contains the following eight Chinese herbs: *Radix Angelicae* Sinensis, *Radix Paeoniae* Alba, *Poria*, *Radix Bupleuri*, *Rhizoma Atractylodis* Macrocephalae, *Radix Gly­cyrrhizae*, *Herba Menthae* and *Rhizoma Zingiberis* Recens (ratio: 3:3:3:3:3:1.5:1:1). These herbs were purchased from Beijing Tongrentang Group Co., Ltd. (Beijing, China). and extracted in a Chinese medicine preparation room of China--Japan Friendship Hospital according to a previous study.[@b21-ndt-15-021] The extraction rate was 18.8%, and the HPLC-mass spectrometry analysis (LC-MS/MS) was used to identify the eight compounds of Xiaoyaosan samples.[@b16-ndt-15-021]

CIS and medication process
--------------------------

A total of 48 rats were randomly divided into the following four groups according to their body weights: control group (no stress with physiological saline, n=12), CIS group (CIS with physiological saline, n=12), Xiaoyaosan group (CIS with Xiaoyaosan treatment, n=12) and fluoxetine group (CIS with fluoxetine treatment, n=12). The CIS procedure is shown in [Figure 1](#f1-ndt-15-021){ref-type="fig"} and performed as previously described.[@b22-ndt-15-021] Briefly, the rats in the CIS, Xiaoyaosan and fluoxetine groups were exposed to a homemade apparatus, which was used to immobilize rats. This apparatus was composed of wooden double-binding platforms, including a lower platform (20×10×2.8 cm) and an upper platform (22×6.6×2.8 cm). In front of the upper platform, a small frame suitable was located for immobilizing a rat head. Meanwhile, two pieces of soft, adjustable bands were used to fix the upper body and waist of a rat on the upper platform. The rats were immobilized in this apparatus for 3 hours a day, without free access to food or water, and CIS was performed for successive 21 days. Rats in the two treatment groups received Xiaoyaosan (3.854 g/kg/d, 0.1 mL/kg bodyweight) and fluoxetine (2 mg/kg/d, 0.1 mL/kg bodyweight) by intragastric administration after the daily immobilization procedure, respectively. Meanwhile, rats in the control and CIS groups received physiological saline (0.1 mL/kg bodyweight). Furthermore, to observe the behaviors of the rats during the CIS process, the body weight and food intake were recorded weekly (days 0, 7, 14 and 21), and the data of the day before experiment were used as baseline (day 0). The other behavioral assessments such as OFT (days 0 and 21), SPT (days 0 and 21) and NSF (day 21) were performed before or after the CIS procedure.

Sucrose preference test (SPT)
-----------------------------

The SPT was carried out before and after the stress period (days 0 and 21), and it was performed as described in a previous study.[@b23-ndt-15-021] In short, each rat received two bottles of 1% sucrose solution for 24 hours; then one filled with 1% sucrose solution and the other with pure water for another 24 hours. After fasting and water deprivation for 24 hours, each rat received two bottles filled with pure water and 1% sucrose solution for 1 hour. The ratio of consumption of sucrose solution to that of total solution within 1 hour was recorded, which could be the objective indicator of hedonic behavior.

Novelty suppressed feeding (NSF) test
-------------------------------------

The NSF test was conducted at day 21 using the previously described method.[@b24-ndt-15-021] Briefly, a white plastic box was prepared (50×50×40 cm) with a single pellet of regular chow placed in the center. After food deprivation for 24 hours, the rats were individually placed in the corner of the plastic box. The time that the rats began to chew the food pellet was recorded up to 5 minutes as the feeding latency in the novelty environment. The box was cleaned, and the food pellet was replaced after each test.

Open field test (OFT)
---------------------

The OFT was performed before and after the CIS process (days 0 and 21) based on the previously described procedure.[@b25-ndt-15-021] A wooden box with open bottom (125×125×50 cm) was prepared, and the test was performed in a light- and sound-attenuated room with a dim light. The movement condition of rats in each group was recorded for 5 minutes by an HD camera. The Etho Vision 3.0 software (Noldus, Wageningen, Holland) was used to record the locomotor ability of each rat (lattice number, residence time and number of entries into central area).

Preparation of tissues
----------------------

After 21 days of CIS modeling, all rats in four groups were anesthetized by an intraperitoneal injection of 10% chloral hydrate. The hippocampal tissues of six rats in each group were collected for protein analysis (Western blot and ELISA analyses), and then hypothalamic tissues of the other six rats in each group were collected with RNA preservation solution (Biotech, \#2714) for qRT-PCR assay.

qRT-PCR analysis
----------------

The levels of TPH2 and IDO1 mRNAs in the hippocampus were evaluated by qRT-PCR assay. The total RNA of hypothalamus was extracted using Trizol reagent (Thermo Fisher Scientific, Waltham, MA, USA). Then, the concentration and quality of total RNA were determined by Q3000 micro-volume spectrophotometer (Quawell Technology, San Jose, CA, USA) and 1% agarose gel electrophoresis. The RevertAid First Strand cDNA Synthesis Kit (Thermo Fisher Scientific) was used to synthesize first-strand cDNA on C1000 Touch TM Thermal Cycler (Bio-Rad Laboratories Inc., Hercules, CA, USA) according to the standard protocol. The SYBR^®^ Green PCR Master Mix (Thermo Fisher Scientific) was used to amplify the cDNA in the Multicolor Real-time PCR Detection System (Bio-Rad Laboratories Inc.), and the cycling parameters were as follows: 95°C for 10 minutes, followed by 40 cycles of 95°C for 15 seconds and 56°C (TPH2) or 58°C (IDO1) for 1 minute, then followed by 65°C for 5 seconds and 95°C for 15 seconds. The 2^−∆∆Ct^ method was used to calculate the expression of mRNA. [Table 1](#t1-ndt-15-021){ref-type="table"} shows the sequences for primers, which were designed according to the published mRNA sequences in NCBI, and *GAPDH* (BBI Life Science, Amherst, MA, USA) was used as the house-keeping gene in the experiment.

Western blot analysis
---------------------

The expression of the TPH2 and IDO1 proteins in the hippocampus was detected by Western blot. The hippocampal tissues were used to prepare the total proteins with RIPA Lysis buffer (Biomiga, Santiago, CA, USA). The 10% SDS-PAGE gels were selected according to relative molecular weight of TPH2 (56 kDa) and IDO1 (45 kDa), and then proteins were transferred onto polyvinylidene fluoride (PVDF) membranes. The 5% nonfat milk was used to block the membranes, and the primary antibodies were anti-TPH2 antibody (ab121013, goat polyclonal to TPH2, diluted 1:500; Abcam, San Francisco, CA, USA), anti-indoleamine 2,3-dioxygenase antibody (ab106134, rabbit polyclonal to indoleamine 2,3-dioxygenase, diluted 1:50; Abcam) and β-actin monoclonal antibody (MA1-140, mouse monoclonal to β-actin, diluted 1:3,000; Thermo Fisher Scientific). The enhanced chemiluminescence (ECL) detection reagent (Thermo Fisher Scientific) was used to develop the membranes for 1 minute, and then the Tanon-5200 system (Tanon, Shanghai, China) was used for exposure. The optical density of protein bands was read by Tanon Gis software (Tanon).

ELISA analysis
--------------

The weight of each hippocampal tissue was recorded, and then pulverized with pre-cooling PBS (0.01 M, pH 7.4) in a certain ratio (tissue weight: PBS volume=1 mg: 9 µL) and centrifuged to prepare the diluted samples. The contents of 5-HT and tryptophan were measured by ELISA assay (Serotonin ELISA kit, ADI-900-175; Enzo, New York, NY, USA and Tryptophan ELISA kit, KA1916; Abnova, Taipei City, China) according to the standard protocol of the kits. The mean optical density was detected using the Multiskan™ GO (Thermo Fisher Scientific) Detector system at a wavelength of 405 nm (5-HT) or 450 nm (tryptophan), and the content was calculated according to the standard curves and relative regression equations.

Statistical methods
-------------------

All data were expressed as mean ± standard error of the mean (SEM) and analyzed by the SPSS 21.0 software, one-way ANOVA or nonparametric test was performed for general data based on the normality test and the homogeneity test for variance, and the least significant difference (LSD) method was used for post hoc comparisons when equal variances were assumed, whereas Dunnett's T3 test was used when the data had a normal distribution but the variances are not homogeneous. In addition, repeated measurement process of general linear model (GLM) was measured to conduct one-way ANOVA for repeated measured data such as body weight and food intake. A *P*-value of \<0.05 was considered statistically significant, and the GraphPad Prism 6.0 software was used to draw statistical graphs.

Results
=======

Xiaoyaosan improved food intake and body weight of chronic stress-depressed rats
--------------------------------------------------------------------------------

In order to evaluate the efficacy of Xiaoyaosan to the physical condition of CIS-exposed rats, the data of food intake and body weight were recorded and analyzed. [Figure 2](#f2-ndt-15-021){ref-type="fig"} shows that the body weight and food intake of rats in each group had no significant differences at day 0, but difference appeared gradually as the CIS procedure continued. On day 21, the body weight and food intake between the CIS group and the control group were significantly different (body weight: f(3, 44)=4.685, food intake: f(3, 44)=4.025, both *P*\<0.01), while the treatment of both Xiaoyaosan and fluoxetine could significantly improve the food intake and body weight compared with the CIS group (both *P*\<0.01).

Xiaoyaosan improved depressive-like behaviors of chronic stress-depressed rats
------------------------------------------------------------------------------

Several behavioral assessments were carried out to further evaluate the efficacy of Xiaoyaosan to depressive-like behaviors of CIS-exposed rats. As shown in the SPT results, each group had a similar sucrose preference baseline at day 0 (f(3, 44)=4.163, *P*\>0.05; [Figure 3A](#f3-ndt-15-021){ref-type="fig"}), and after modeling for 21 days, the sucrose preference of rats in the CIS group significantly decreased compared with the rats in the control group (f(3, 44)=4.928, *P*\<0.01; [Figure 3B](#f3-ndt-15-021){ref-type="fig"}); Xiaoyaosan or fluoxetine treatment could significantly reverse the reduction of sucrose preference (both *P*\<0.01). As shown in the NSF test, the latency to eat the chow represented the degree of anxiety/depression in the CIS-exposed rats. It was shown that CIS rats had a longer latency to chew the chow than the control rats and had a significant difference (f(3, 44)=4.129, *P*\<0.01; [Figure 3C](#f3-ndt-15-021){ref-type="fig"}). The latencies of rats in two treatment groups were significantly lower than those of the CIS rats (both *P*\<0.05). [Figure 3D](#f3-ndt-15-021){ref-type="fig"} shows a representative moving trail of rats in each group at day 21. The OFT results showed that baselines of all the groups had no obvious difference at day 0 (number of entries into the central area: f(3, 44)=2.096, residence time: f(3, 44)=0.571, lattice number: f(3, 44)=0.876, both *P*\>0.05; [Figure 3E, G and I](#f3-ndt-15-021){ref-type="fig"}). After modeling for 21 days, the behaviors of the CIS-exposed rats were significantly different from the control rats (number of entries into the central area: f(3, 44)=2.113, residence time: f(3, 44)=4.017, lattice number: f(3, 44)=4.366, both *P*\<0.01; [Figure 3F, H and J](#f3-ndt-15-021){ref-type="fig"}). Both Xiaoyaosan and fluoxetine treatments could remarkably reverse these depressive-related behavioral changes (*P*\<0.05 and *P*\<0.01, respectively).

Xiaoyaosan improved the tryptophan metabolism in the hippocampi of chronic stress-depressed rats
------------------------------------------------------------------------------------------------

In order to observe the mechanisms that Xiaoyaosan regulated the tryptophan metabolism in the hippocampi of chronic stress-depressed rats, the expression levels of TPH2 and IDO1 were measured, while the contents of 5-HT and tryptophan were detected. The mRNA and protein expression results revealed that the 21-day CIS decreased the TPH2 levels in the hypothalamus of chronic stress-depressed rats (TPH2 mRNA: f(3, 20)=6.643, TPH2/β-actin: f(3, 20)=5.003, both *P*\<0.05; [Figure 4A and C](#f4-ndt-15-021){ref-type="fig"}), and the TPH2 levels of rats in the Xiaoyaosan and fluoxetine groups significantly increased compared with the CIS rats (both *P*\<0.05). The 21-day CIS also increased the IDO1 levels in the hypothalamus (IDO1 mRNA: f(3, 20)=19.170828, IDO1/β-actin: f(3, 20)=1.466, both *P*\<0.01; [Figure 4B and D](#f4-ndt-15-021){ref-type="fig"}), both Xiaoyaosan and fluoxetine could significantly inhibit the increase in IDO1 level compared with the CIS group (both *P*\<0.01).

The standard curves in this study were constructed by plotting the peak area of gradient concentrations of the two reference standards. The calibration curves were as follows: y= −0.129ln(x)+0.9349 (R[@b2-ndt-15-021]=0.995, 5-HT) and y= −0.148ln(x)+1.0092 (R[@b2-ndt-15-021]=0.993, tryptophan). Compared with the control group, the contents of 5-HT in the hippocampi of CIS rats obviously decreased (f(3, 20)=4.076, *P*\<0.01; [Figure 4E](#f4-ndt-15-021){ref-type="fig"}), whereas the content of tryptophan significantly increased (f (3, 20)=3.181, *P*\<0.01; [Figure 4F](#f4-ndt-15-021){ref-type="fig"}). The treatment of Xiaoyaosan or fluoxetine could remarkably reverse the changes in 5-HT and tryptophan contents (*P*\<0.05 and *P*\<0.01, respectively).

Discussion
==========

The purpose of this study is to explore the pathogenesis of depression and the effect of Xiaoyaosan on the tryptophan metabolism, which was responsible for the increase in the synthesis and function of 5-HT. Immobilization stress, as a significant stress measure, has been widely applied in various animal experiments.[@b26-ndt-15-021],[@b27-ndt-15-021] The CIS-induced model, to a certain extent, simulates the state of depression in clinic.[@b28-ndt-15-021],[@b29-ndt-15-021] In this study, we found that Xiaoyaosan can alleviate the depressive-like behaviors in a rat model of depression built by the 21-day CIS. Our findings suggested that the treatment of Xiaoyaosan regulates the concentrations of 5-HT and tryptophan mainly by upregulating TPH2 expression, as well as downregulating IDO1 expression in the hippocampi of depressed rats.

Depression, as a complex public health problem, has been widely studied for many years. But until now, it has become a major cause of medical disability worldwide and is a serious threat to human health.[@b30-ndt-15-021] In order to reduce the detriment brought by depression, it is an effective way to determine the pathogenesis of depression by studying the mechanism of traditional Chinese medicine with antidepressant effect. Stress is a systemic non-specific adaptation reaction when the body is stimulated by various internal and external environmental factors, and it is closely related to the occurrence and development of many diseases. Mental disorders and cognitive impairment caused by stress are closely related to the limbic system and the important brain regions such as hypothalamus.[@b31-ndt-15-021],[@b32-ndt-15-021] Meanwhile, life stressor is an important inducing factor of clinical depression, thus stress is one of the important causes of mental disorders such as depression and anxiety.[@b33-ndt-15-021]

The SPT is a common method to observe the anhedonia induced by depression, and the decreased sucrose preference is a crucial indicator of depressive-like behaviors in rodents.[@b34-ndt-15-021],[@b35-ndt-15-021] As shown in our results, the differences in sucrose preference between control and CIS groups indicate the presence of obvious anhedonia and depression in the CIS rats. The NSF test was used to determine the animal's mental and behavioral changes by observing the feeding latency of animals in a novelty environment.[@b36-ndt-15-021] The results revealed that the feeding latency of rats in the CIS group was significantly longer than that in the control group, which verified the depressive-like changes in the CIS rats. The OFT was carried out to evaluate the autonomous exploration of animals in a new environment and commonly used in the evaluation of animal models such as depression and anxiety.[@b37-ndt-15-021],[@b38-ndt-15-021] In this study, the lattice number, residence time and the number of entries into central area were analyzed. When the rats were in a state of anxiety or depression, it would take the initiative to avoid the open central area, choose to move around the box and reduce the number of entries into central area. Once entered into the open central area, the rats with depressive-like changes would be hesitant to move around, thus increasing the residence time. The lattice number mainly reflected that the total movement of experimental animals, the spontaneous activity and locomotor ability of rats decreased when exposed to CIS. According to the results, there were significant differences in the lattice number, residence time and the number of entries into central area in the CIS group compared with the control group, which further confirmed that CIS would cause depressive-like behaviors in the CIS group. Previous studies in clinical and animal experiments suggested that Xiaoyaosan had good relieving effects on depressive-like behaviors.[@b39-ndt-15-021],[@b40-ndt-15-021] We had similar behavioral results in this study, wherein both Xiaoyaosan and fluoxetine treatments had a reasonable antidepressant-like effect according to the results of behavior tests, and fluoxetine was used as a positive control drug to verify the antidepressant-like effect of Xiaoyaosan. In addition, persistent stress and depression often led to low appetite and weight loss.[@b41-ndt-15-021],[@b42-ndt-15-021] During the CIS process, the difference in general states between the model group and the control group gradually became obvious, which confirmed the general manifestation of stress-induced depression.[@b43-ndt-15-021] Our results indicated that Xiaoyaosan could effectively regulate appetite and the body weight of the CIS rats.

The decrease in 5-HT in the central nervous system could increase the body sensitivity to external stress and change the mental state, resulting in mental diseases such as depression and anxiety.[@b44-ndt-15-021] 5-HT was the most important intermediate product in the tryptophan metabolism. When the metabolism speed was accelerated due to stress, the level of tryptophan decreased, and then the content of 5-HT decreased and caused mental disorders.[@b45-ndt-15-021] The results of this study showed a dysfunction of tryptophan metabolism in the CIS-induced rats, which is manifested by an increased level of tryptophan and a decreased level of 5-HT in the hippocampus. At the same time, the expression of TPH2 and IDO1 in the hippocampi of rats in the CIS group changed. CIS could cause an upregulation of the expression of IDO1 and a downregulation of the expression of TPH2, which suggested that CIS might inhibit the tryptophan metabolism to reduce the content of 5-HT in the hippocampi of rats. TPH2 was abundant in the hippocampus and raphe nuclei;[@b46-ndt-15-021] it mainly controlled the synthesis of 5-HT in the central nervous system.[@b47-ndt-15-021] This meant that the decreased level of TPH2 may reduce the utilization rate of tryptophan and cause depression.[@b48-ndt-15-021] The CIS may lead to a decrease in the utilization of tryptophan, followed by a decrease in 5-HT biosynthesis, which may be one of the important mechanisms of depression. IDO included two homologous proteins, IDO1 and IDO2, which were similar in structure and function.[@b49-ndt-15-021] There was a positive correlation between the content of IDO and depressive-like symptoms.[@b50-ndt-15-021] IDO1, one of the main indicators in this study, was closely related to monoamine neurotransmitters, cytokines and neuronal plasticity that played an important role in the pathogenesis and treatment of mental diseases.[@b51-ndt-15-021] Excessive expression of IDO1 accelerated the consumption of 5-HT and produced more kynurenine from tryptophan metabolism. Tryptophan was an essential amino acid and a precursor substance of 5-HT. The decrease in tryptophan would lead to a decrease in 5-HT in the absence of outside intake.[@b52-ndt-15-021] In addition, some of the metabolites of the tryptophan--kynurenine pathway such as 3-hydroxykynurenine and quinolinic acid had neurotoxic effects under the action of IDO1, which might cause the degeneration of neurons and affect the neural plasticity.[@b53-ndt-15-021],[@b54-ndt-15-021] TPH2, as a key enzyme, directly regulated the synthesis of 5-HT, and IDO1 indirectly affected the 5-HT level by forcing the breakdown of tryptophan into kynurenine. Therefore, as shown in [Figure 5](#f5-ndt-15-021){ref-type="fig"}, CIS could cause the abnormal expression of TPH2 and IDO1 in the hippocampus, which affected the tryptophan metabolism and the content of 5-HT. When the body was exposed to stress, tryptophan was overconsumed because of the excessive expression of IDO1. Meanwhile, the synthesis of 5-HT decreased due to tryptophan metabolism because of the downregulation of the expression of TPH2, which further increased the body's sensitivity to stress and then aggravated depressive symptoms.

As shown in the results, Xiaoyaosan and fluoxetine could regulate the expression of TPH2 and IDO1 in the hippocampi of the rats exposed to CIS. The two drugs could allow more tryptophan to metabolize into 5-HT, had a certain recovery effect on the dysfunction of the 5-HT system and then played the antidepressant-like effect. A previous study had shown that fluoxetine has an upregulation effect on the expression of TPH2 in hippocampus,[@b55-ndt-15-021] and fluoxetine could effectively inhibit the IDO activity to exert its anti-inflammatory effects,[@b56-ndt-15-021] which was consistent with the results in the study. At present, selective serotonin reuptake inhibitor (SSRI) drugs such as fluoxetine were used in treating depression, which could increase the concentration of 5-HT in the synaptic cleft to exert antidepressant-like effects. However, the SSRI drugs also had some limitations in the treatment of depression. If the tryptophan could not be replenished in time, it caused the deficiency of 5-HT in the presynaptic membrane and then produced a rapid resistant reaction and weakened the curative effect.[@b57-ndt-15-021] In this study, there is no report that Xiaoyaosan had such side effects as SSRI drugs, and the antidepressant mechanism of Xiaoyaosan was gradually revealed. We concluded from the present results that Xiaoyaosan had beneficial effects on a CIS rat model through regulating the expressions of THP2 and IDO1 and then affecting tryptophan metabolism and 5-HT system.

However, there still existed several limitations in this study. First, the TPH2 mRNA level in the two treatment groups was different from the control group, which was inconsistent with the results of protein expression, and hence an expanded sample size might avoid this problem. Second, this study only detected the 5-HT-related tryptophan metabolism in hippocampus, whereas amygdalae or raphe nuclei might be potential research points to expound the regulative mechanism of Xiaoyaosan. Third, further studies are needed to examine the effective ingredients of Xiaoyaosan, as well as the specific role of Xiaoyaosan in the regulation of the tryptophan metabolism. For future studies, it is necessary to explore the related brain regions and substances of the 5-HT system, then seek the relationship between the antidepressant-like effect of Xiaoyaosan and the monoamine neurotransmitter system, which will help to determine the pathogenesis of depression and provide a comprehensive basis for the application of Xiaoyaosan.

Conclusion
==========

In this study, a rat model of depression was successfully established by 21-day CIS. The study proved that Xiaoyaosan played an antidepressant-like effect by regulating the levels of 5-HT, tryptophan, TPH2, and IDO1 in the tryptophan metabolism. As a classic Chinese formula with comprehensive efficacy, Xiaoyaosan had a wide range of applications and could treat mental diseases such as depression and anxiety, and it was worth popularizing in clinical treatment.
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![Study schedule.\
**Notes:** CIS and drug administration were conducted for successive 21 days; the body weight and food intake were recorded at days 0, 7, 14 and 21; SPT and OFT were performed at day 0, and then SPT, NSF and OFT were performed at day 21; rats were sacrificed at day 22.\
**Abbreviations:** CIS, chronic immobilization stress; NSF, novelty suppressed feeding test; OFT, open field test; SAC, sacrificed; SPT, sucrose preference test.](ndt-15-021Fig1){#f1-ndt-15-021}

![Changes in the food intake and body weight of chronic stress-depressed rats.\
**Notes:** (**A**) Changes in food intake during the modeling period (n=12). (**B**) Changes in body weight during the modeling period (n=12). Data are expressed as mean ± SEM, ^\*\*^*P*\<0.01 vs the control group; ^∆∆^*P*\<0.01 vs the CIS group.\
**Abbreviations:** CIS, chronic immobilization stress; SEM, standard error of the mean.](ndt-15-021Fig2){#f2-ndt-15-021}

![Changes in the depressive-like behaviors of chronic stress-depressed rats.\
**Notes:** (**A**) SPT results at day 0 (baseline, n=12); (**B**) SPT results at day 21 (n=12); and (**C**) NSF results at day 21 (n=12). (**D**) The representative moving trails of rats in each group at day 21 assessed by video tracking software. (**E**) The results of number of entries into the central area at day 0 (baseline, n=12). (**F**) The results of number of entries into the central area at day 21 (n=12). (**G**) The results of residence time at day 0 (baseline, n=12). (**H**) The results of residence time at day 21 (n=12). (**I**) The results of lattice number at day 0 (baseline, n=12). (**J**) The results of lattice number at day 21 (n=12). Data were expressed as mean ± SEM, ^\*\*^*P*\<0.01 vs the control group; ^∆^*P*\<0.05, ^∆∆^*P*\<0.01 vs the CIS group.\
**Abbreviations:** CIS, chronic immobilization stress; NSF, novelty suppressed feeding; SEM, standard error of the mean; sec, seconds; SPT, sucrose preference test.](ndt-15-021Fig3){#f3-ndt-15-021}

![Changes in the hippocampal tryptophan metabolism of chronic stress-depressed rats.\
**Notes:** (**A**) The mRNA results of TPH2 (n=6). (**B**) The mRNA results of IDO1 (n=6). (**C**) The protein results of TPH2 (n=6). (**D**) The protein results of IDO1 (n=6). (**E**) The results of 5-HT contents (n=6). (**F**) The results of tryptophan contents (n=6). Data were expressed as mean ± SEM, ^\*^*P*\<0.05, ^\*\*^*P*\<0.01 vs the control group; ^∆^*P*\<0.05, ^∆∆^*P*\<0.01 vs the CIS group.\
**Abbreviations:** CIS, chronic immobilization stress; 5-HT, 5-hydroxytryptamine; IDO1, indoleamine 2,3-dioxygenase 1; SEM, standard error of the mean; TPH2, tryptophan hydrogenase 2.](ndt-15-021Fig4){#f4-ndt-15-021}

![Effects of Xiaoyaosan on CIS-induced changes in hippocampal tryptophan metabolism.\
**Notes:** The behaviors of chronic stress-depressed rats were obviously improved by Xiaoyaosan treatment. The contents of tryptophan and 5-HT and the protein and mRNA levels of TPH2 and IDO1 in the hippocampus were influenced by the CIS; these irregular changes could be effectively reversed by the treatment with Xiaoyaosan.\
**Abbreviations:** CIS, chronic immobilization stress; 5-HT, 5-hydroxytryptamine; IDO1, indoleamine 2,3-dioxygenase 1; TPH2, tryptophan hydrogenase 2.](ndt-15-021Fig5){#f5-ndt-15-021}

###### 

Primer sequences used in the qRT-PCR analysis

  Gene       Sequences
  ---------- ----------------------------
             
  *TPH2*     
   Forward   5′-CCATCGGAGAATTGAAGCAT-3′
   Reverse   5′-TTGGAAGGTGGTGATTAGGC-3′
  *IDO1*     
   Forward   5′-GGGCTTTGCTCTACCACATC-3′
   Reverse   5′-GCTTCCCATTCTCAATCAGC-3′

**Abbreviations:** IDO1, indoleamine 2,3-dioxygenase 1; qRT-PCR, quantificational real-time polymerase chain reaction; TPH2, tryptophan hydrogenase 2.
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